Advertisement

Molecular and Cellular Biochemistry

, Volume 377, Issue 1–2, pp 23–33 | Cite as

Protective effects of azelaic acid against high-fat diet-induced oxidative stress in liver, kidney and heart of C57BL/6J mice

  • Shanmugam Muthulakshmi
  • Ramalingam Saravanan
Article

Abstract

Excess fat intake induces hyperinsulinaemia, increases nutrient uptake and lipid accumulation, amplifies ROS generation, establishes oxidative stress and morphological changes leading to tissue injury in the liver, kidney and heart of high-fat diet (HFD)-fed mice. The effect of azelaic acid (AzA), a C9 α,ω-dicarboxylic acid, against HFD-induced oxidative stress was investigated by assaying the activities and levels of antioxidants and oxidative stress markers in the liver, kidney and heart of C57BL/6J mice. Mice were segregated into two groups, one fed standard diet (NC) and the other fed high-fat diet (HFD) for 15 weeks. HFD-fed mice were subjected to intragastric administration of AzA (80 mg/kg BW)/RSG (10 mg/kg BW) during 11-15 weeks. Glucose, insulin, triglycerides, hepatic and nephritic markers were analysed in the plasma and the activity of enzymatic, non-enzymatic antioxidants and lipid peroxidation markers were examined in the plasma/erythrocytes, liver, kidney and heart of normal and experimental mice. We inferred significant decrease in enzymatic and non-enzymatic antioxidants along with significant increase in glucose, insulin, hepatic and nephritic markers, triglycerides and lipid peroxidation markers in HFD-fed mice. Administration of AzA could positively restore the levels of plasma glucose, insulin, triglycerides, hepatic and nephritic markers to near normal. AzA increased the levels of enzymatic and nonenzymatic antioxidants with significant reduction in the levels of lipid peroxidation markers. Histopathological examination of liver, kidney and heart substantiated these results. Hence, we put forward that AzA could counteract the potential injurious effects of HFD-induced oxidative stress in C57BL/6J mice.

Keywords

Enzymatic antioxidant Non-enzymatic antioxidant Azelaic acid Lipid peroxidation High-fat diet 

Notes

Acknowledgments

The author(s) sincerely thank Indian Council of Medical Research, India for providing financial support for this research project, in the form of Senior Research Fellowship (ICMR-SRF), to Mrs. Shanmugam Muthulakshmi.

Conflict of interest

The authors declared no conflict of interest.

References

  1. 1.
    Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Nakajima Y, Nakayama O (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Investig 114:1752–1761CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Buettner R, Scholmerich J, Bollheimer LC (2007) High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 15:798–808CrossRefPubMedGoogle Scholar
  3. 3.
    Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ, Pitt HA (2007) Nonalcoholic fatty pancreas disease. HPB (Oxford) 9:312–318CrossRefGoogle Scholar
  4. 4.
    Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H (2008) Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Met Clin Exp 57:1071–1077CrossRefGoogle Scholar
  5. 5.
    Reaven G, Abbasi F, McLaughlin T (2004) Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 59:207–223CrossRefPubMedGoogle Scholar
  6. 6.
    Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P (2002) Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 75:767–772PubMedGoogle Scholar
  7. 7.
    Olusi SO (2002) Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotecticve enzymes in humans. Int J Obes 26:1159–1164CrossRefGoogle Scholar
  8. 8.
    Fraulob JC, Diamantino RO, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA (2010) A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 46:212–223CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Nissen SE, Wolski K (2010) Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med 26:1191–1201Google Scholar
  10. 10.
    Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ (2009) Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, openlabel trial. Lancet 373:2125–2135CrossRefPubMedGoogle Scholar
  11. 11.
    Anderson JW, Hanna TJ, Peng X, Kryscio RJ (2000) Whole grain foods and heart disease risk. J Am Coll Nutr 19:291S–299SCrossRefPubMedGoogle Scholar
  12. 12.
    Montonen J, Knekt P, Jarvinen R, Aromaa A, Reunanen A (2007) Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 77:622–629Google Scholar
  13. 13.
    Munter JS, Hu FB, Spiegelman D, Franz M, Dam RMV (2007) Whole grain, bran and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 4:e261CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Mehmood S, Orhan I, Ahsan Z, Aslan S, Gulfraz M (2008) Fatty acid composition of seed oil of different Sorghum bicolor varieties. Food Chem 109:855–859CrossRefPubMedGoogle Scholar
  15. 15.
    Marsden JR, Shuster S (1983) The effect of azelaic acid on acne. Br J Dermatol 109:723–725CrossRefPubMedGoogle Scholar
  16. 16.
    Breathnach AS (1999) Azelaic acid: potential as a general antitumoural agent. Med Hypotheses 52:221–226CrossRefPubMedGoogle Scholar
  17. 17.
    Charnock C, Brudeli B, Klaveness J (2004) Evaluation of the antibacterial efficacy of diesters of azelaic acid. Eur J Pharm Sci 21:589–596CrossRefPubMedGoogle Scholar
  18. 18.
    Nguyen QH, Bui TP (1995) Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol 34:75–84CrossRefPubMedGoogle Scholar
  19. 19.
    Mastrofrancesco A, Ottaviani M, Aspite N (2010) Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPAR gamma activation. Exp Dermatol 19:813–820CrossRefPubMedGoogle Scholar
  20. 20.
    Trinder P (1969) Determination of blood glucose using an oxidase peroxidase system with a non carcinogenic chromogen. J Clin Pathol 22:158–161CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Burgi W, Briner M, Franken N, Kessler ACH (1998) One step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clin Biochem 213:11–314Google Scholar
  22. 22.
    Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamate oxaloacetic and glutamate pyruvic transaminases. Am J Clin Pathol 28:56–63CrossRefPubMedGoogle Scholar
  23. 23.
    Kind PR, King EJ (1954) Estimation of plasma phosphatase by determination of hydrolyzed phenol with amino-antipyrine. J Clin Pathol 7:322–326CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Fawcett JK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Path 3:156–159CrossRefGoogle Scholar
  25. 25.
    Caraway WT (1955) Determination of uric acid in serum by carbonate method. Am J Clin Path 25:840–845PubMedGoogle Scholar
  26. 26.
    Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 21:130–132Google Scholar
  27. 27.
    Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47:389–394CrossRefPubMedGoogle Scholar
  28. 28.
    Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidise. Science 179:588–590CrossRefPubMedGoogle Scholar
  29. 29.
    Habig WH, Pabst MJ, Jakoby WBC (1974) Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem 249(22):7130–7139PubMedGoogle Scholar
  30. 30.
    Pinto RE, Bartley W (1969) The effect of age and sex on glutathione reductase and glutathione peroxidase activities on aerobic glutathione oxidation in rat liver homogenate. Biochem J 12:109–115CrossRefGoogle Scholar
  31. 31.
    Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77CrossRefPubMedGoogle Scholar
  32. 32.
    Roe JH, Kuether CA (1943) The determination of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenylhydrazine derivative of dehydroascorbic acid. J Biol Chem 11:145–164Google Scholar
  33. 33.
    Baker H, Frank O, DeAngelis B, Feingold S (1980) Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Res 21:531–536Google Scholar
  34. 34.
    Niehaus WG, Samuelsson B (1968) Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6:126–130CrossRefPubMedGoogle Scholar
  35. 35.
    Jiang ZY, Hunt JV, Wolff SP (1992) Ferrous ion oxidation in the presence of xylenol orange for the detection of lipid hydroperoxides in low density lipoprotein. Anal Biochem 202:384–389CrossRefPubMedGoogle Scholar
  36. 36.
    Surwit RS, Feinglos MN, Rodin J (1995) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44:645–651CrossRefPubMedGoogle Scholar
  37. 37.
    Mei J, Yu S, Ahren B (2010) Study on administration of 1,5-anhydro-d-fructose in C57BL/6J mice challenged with high-fat diet. BMC Endocr Disord 10(17):1–5Google Scholar
  38. 38.
    Kim MR, Park Y, Albright KJ, Pariza MW (2002) Differential responses of hamsters and rats fed high-fat or low-fat diets supplemented with conjugated linoleic acid. Nutr Res 22:715–722CrossRefGoogle Scholar
  39. 39.
    Gallou-Kabani Vige A, Gross MS (2007) C57BL/6J and A/J mice fed a high fat diet delineate components of metabolic syndrome. Obesity 15:1996–2005CrossRefPubMedGoogle Scholar
  40. 40.
    Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RA, Bogardus C et al (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:1889–1895CrossRefPubMedGoogle Scholar
  41. 41.
    Myers VC, Fine MS (1918) Comparative distribution of urea, creatinine, uric acid and sugar in the blood and spinal fluid. Am J Med Sci 76:239–244Google Scholar
  42. 42.
    Moron MS, Dipierre JW, Mannervik B (1979) Levels of glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582(1):67–68CrossRefPubMedGoogle Scholar
  43. 43.
    Halliwell B, Gutteridge JMC (1990) Role of free radicals and catalytic metal ions in human disease. Methods Enzymol 186:1–85CrossRefPubMedGoogle Scholar
  44. 44.
    Ingold KU, Webb AC, Witter D, Burton GW, Metcalf TA, Muller DP (1987) Vitamin E remains the major lipid soluble, chain breaking antioxidant in human plasma even in individuals suffering from severe vitamin E deficiency. Arch Biochem Biophys 259(1):224–225CrossRefPubMedGoogle Scholar
  45. 45.
    Packer L, Tritschler HJ, Wessel K (1997) Neuroprotection by metabolic antioxidant alpha lipoic acid. Free Radic Biol Med 22(1–2):359–378CrossRefPubMedGoogle Scholar
  46. 46.
    Freisleben HJ, Packer L (1993) Free-radical scavenging activities, interactions and recycling of antioxidants. Biochem Soc Trans 21(2):325–330CrossRefPubMedGoogle Scholar
  47. 47.
    Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88CrossRefPubMedGoogle Scholar
  48. 48.
    Cathcart RF (1985) Vitamin C: the nontoxic, nonrate-limited, antioxidant free radical scavenger. Med Hypotheses 18(1):61–77CrossRefPubMedGoogle Scholar
  49. 49.
    Godin DV, Wohaieb SA, Garnett ME, Goumeniouk AD (1988) Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84:223–231CrossRefPubMedGoogle Scholar
  50. 50.
    Baynes JW (1991) Perspectives in diabetes: role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412CrossRefPubMedGoogle Scholar
  51. 51.
    Rizvi SI, Maurya PK (2007) Markers of oxidative stress in erythrocytes during aging in humans. Ann N Y Acad Sci 1100:373–382CrossRefPubMedGoogle Scholar
  52. 52.
    Haggai MC, Nieto N (2005) A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 19:136–138Google Scholar
  53. 53.
    Agarwal R, Vasavada N, Sachs NG, Chase S (2004) Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int 65:2279–2289CrossRefPubMedGoogle Scholar
  54. 54.
    Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Kanasaki M (2007) Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 18:2715–2723CrossRefPubMedGoogle Scholar
  55. 55.
    Bournoville ML, Conti M, Bazin R, Michel O, Bariéty J, Chevalier J (1999) Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. Nephrol Dial Transpl 15(4):467–476Google Scholar
  56. 56.
    Vincent HK, Powers SK, Dirks AJ, Scarpace P (2001) Mechanism for obesity induced increase in myocardial lipid peroxidation. Int J Obes 25:378–388CrossRefGoogle Scholar
  57. 57.
    Esterbauer H, Gebicki J, Puhl H, Jurgens G (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol Med 13:341–390CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Biochemistry and Biotechnology, Faculty of ScienceAnnamalai UniversityTamil NaduIndia

Personalised recommendations